Drug Delivery Polymer Market Size, Growth, In-depth Analysis, Research Report Forecast up to 2027: Poly-Med, Inc. and Henkel Corporation are key players.

The drug delivery polymer market is expected to grow at a CAGR of 8.90% to reach a market size worth US$29.535 billion by 2027.

The prime factors propelling the growth of the drug delivery polymer market are:

• The increasing prevalence of chronic diseases.
• Rising demand for targeted drug delivery.
• Technological advancements in drug delivery systems.

The drug delivery polymer market is expected to grow rapidly during the forecast period.

Polymer-based drug delivery systems have emerged as an effective approach for the targeted and sustained delivery of drugs to specific sites in the body. These systems are designed to overcome the limitations of conventional drug delivery methods, such as poor bioavailability, limited drug solubility, and lack of specificity. Polymer-based drug delivery systems offer several advantages, including improved drug efficacy, reduced side effects, and increased patient compliance. Polymers used in drug delivery systems can be classified into various categories, including synthetic and natural polymers. Polymer-based drug delivery systems can be designed to achieve different drug release profiles, including immediate, sustained, and controlled releases. These systems can also be designed to respond to different stimuli, such as pH, temperature, and enzymatic activity, enabling targeted and triggered drug release.

Sample request or complete report can be purchased through the link below:
https://www.knowledge-sourcing.com/report/drug-delivery-polymer-market

The drug delivery polymer market has been categorized based on material type, drug delivery application, end-user, and geography.

By material type, the market has been classified into PLGA (Polylactic-co-glycolic acid), PGA (Poly-l-glutamic acid), polylactic acid (Biodegradable), temperature-responsive polymer, organic polymer, and others. PLGA is a biodegradable polymer widely used in drug delivery systems due to its biocompatibility and biodegradability. PLGA-based drug delivery systems offer several advantages, such as controlled release, sustained drug release, targeted drug delivery, and reduced toxicity. PGA is a water-soluble biodegradable polymer commonly used in drug delivery systems due to its biocompatibility and biodegradability. Temperature-responsive polymers are materials that change their physical properties in response to temperature changes. These polymers are commonly used in drug delivery systems to achieve controlled drug release at specific temperatures.

The market has been classified by drug delivery application into diffusion-controlled, solvent activated, biodegradable, or chemically controlled, and externally triggered (i.e., pH, temperature, etc.). The diffusion-controlled release is one of the most common methods used in polymer-based drug delivery systems. On the other hand, biodegradable or chemically controlled release is used in polymer-based drug delivery systems where the drug is released from the polymer matrix by biodegradation or chemical reactions.

By end-user, the market has been classified into academic and research institutes, hospitals, and pharmaceutical companies. Academic and research institutes play a crucial role in developing polymer-based drug delivery systems. These institutes are involved in basic research and development of new polymers, drug delivery methods, and drug formulations. They also collaborate with pharmaceutical companies to commercialize new drug delivery systems. Hospitals are another significant end-user of polymer-based drug delivery systems. These systems are used to deliver drugs to treat various diseases, including cancer, cardiovascular diseases, and neurological disorders. Polymer-based drug delivery systems offer several advantages over traditional drug delivery methods, such as improved drug efficacy, reduced side effects, and increased patient compliance.

The market is classified geographically into North America, South America, Europe, Middle East and Africa and Asia Pacific. North America holds a significant share of the global drug delivery polymer market, owing to a well-established pharmaceutical industry, significant research and development activities, and a large patient population. Europe is another significant market for polymer-based drug delivery systems, driven by the increasing prevalence of chronic diseases like cancer, cardiovascular diseases, and diabetes. In addition, the presence of many pharmaceutical companies and research institutes also contributes to the growth of the European market.
As a part of the report, the major players operating in the drug delivery polymer market that have been covered are Adhex Pharma, Chempilots a/s, Bezwada Biomedical, LLC., POLYVATION BV, Poly-Med, Inc., Henkel Corporation, Evonik Industries AG, ULTROXA® Polymers, IBMM/PHBM, Serina Therapeutics, and The Lubrizol Corporation.

This Drug Delivery Polymer Market has been analyzed into the following segments:

• By Material Type

o PLGA (Polylactic-co-glycolic acid)
o PGA (Poly-l-glutamic acid)
o Polylactic acid (Biodegradable)
o Temperature responsive polymer
o Organic polymer
o Others

• By Drug Delivery Application

o Diffusion-controlled
o Solvent activated
o Biodegradable or chemically controlled
o Externally triggered (i.e., pH, temperature, etc.)

• By End-User

o Academic and Research Institutes
o Hospitals
o Pharmaceutical Companies

• By Geography

o North Americas

• USA
• Canada
• Mexico

o South America

• Brazil
• Argentina
• Others

o Europe

• Germany
• France
• UK
• Spain
• Others

o Middle East & Africa

• Saudi Arabia
• Israel
• Others

o Asia Pacific

• China
• Japan
• India
• South Korea
• Others

Related Reports:

• Injectable Drug Delivery Market
https://www.knowledge-sourcing.com/report/injectable-drug-delivery-market

• Nasal Drug Delivery Market
https://www.knowledge-sourcing.com/report/nasal-drug-delivery-market

Contact Us:

Knowledge Sourcing Intelligence
Phone: +1-850-250-1698
E-Mail:info@knowledge-sourcing.com

Knowledge Sourcing Intelligence (KSI) is a market research and consulting firm publishing market research studies across ten industry verticals. KSI has a team of experienced and young professionals who focus on delivering high-quality research services to enterprises, non-government organizations, government agencies, and research institutes and organizations. We publish hundreds of reports annually centering on the niche and latest technologies. In addition, we engage with key decision-makers and stakeholders across the value chain to provide clients with a detailed analysis and bird's-eye view of the market with complete market dynamics, statistical forecasts, competitive analysis, key trends, market drivers, and challenges, and strategic recommendations for making informed decisions. Our success lies in our analysts' efforts to meet client expectations by delivering quality work within the stipulated deadlines.

This release was published on openPR.